Left ventricular thrombosis and endogenous endophthalmitis in the setting of COVID‐19: A case report

Zibaeenezhad, Mohammad Javad; Moaref, Alireza; Abtahi, Firoozeh; Moghadami, Mohsen; Johari, Mohammadkarim; Ardekani, Ali; Keshavarz, Mohammad

doi:10.1002/ccr3.5821

Cited by 6 publications

(2 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The treatment was successful, and the patient was discharged on warfarin, with a good outcome at the two-month follow-up. We also mention the case of a patient who developed a thrombus in an LV with normal wall motion [ 105 ].…”

Section: The Use Of Doacs In Patients With LV Thrombusmentioning

confidence: 99%

Direct Oral Anticoagulants for Stroke and Systemic Embolism Prevention in Patients with Left Ventricular Thrombus

Bădescu

Șorodoc

Lionte

et al. 2023

JPM

View full text Add to dashboard Cite

In recent years, direct oral anticoagulants (DOAC) have accumulated evidence of efficacy and safety in various clinical scenarios and are approved for a wide spectrum of indications. Still, they are currently used off-label for left ventricular thrombus owing to a paucity of evidence. For the same reason, there is a lack of guideline indication as well. Our work is based on an exhaustive analysis of the available literature and provides a structured and detailed update on the use of DOACs in patients with left ventricle thrombus. The safety and efficacy of DOACs were analyzed in particular clinical scenarios. As far as we know, this is the first paper that analyzes DOACs in this approach.

show abstract

Section: The Use Of Doacs In Patients With LV Thrombusmentioning

confidence: 99%

Direct Oral Anticoagulants for Stroke and Systemic Embolism Prevention in Patients with Left Ventricular Thrombus

Bădescu

Șorodoc

Lionte

et al. 2023

JPM

View full text Add to dashboard Cite

show abstract

“…COVID-19 adult patients have a wide range of clinical cardiac symptoms. While some patients manifest no clinical evidence of heart disease, some others unveil cardiac manifestations such as myocarditis, myocardial infarction, asymptomatic cardiac arrhythmias, and atrioventricular block (2)(3)(4). Nevertheless, owing to mutual symptoms such as dyspnea, chest pain, and cough, diagnosis of cardiac involvement is usually problematic (5,6).…”

Section: Introductionmentioning

confidence: 99%

ECG Prediction of Mortality in COVID-19 Patients by Sokolow-Lyon Voltage

et al. 2022

View full text Add to dashboard Cite

Background: Different electrocardiographic (ECG) results, seen in coronavirus disease 2019 (COVID-19) patients are most likely due to the combined impact of acute COVID-19 and chronic heart disease. Few studies have addressed the effects of hypoxemia, the hallmark of the pandemic disease, on ECG. Objectives: The present study discusses the prevalence of arrhythmias and disorders of conduction system in demised and survived COVID-19 patients, using ECG and Sokolow-Lyon voltage as a sign of hypoxemia to predict mortality in the admitted patients and after discharge. Methods: We investigated the ECG, and other medical data of 960 COVID-19 patients admitted to Faghihi hospital in Shiraz, Iran, from August 2021 to December 2021. Results: Most of the patients were male (541 or 56.4%) and older than 65 years old (462 or 48.1%). A total of 475 (49.5%) patients died. Multiple logistic regression revealed an independent association between the COVID-19 death rate and cardiovascular disease (OR = 3.05; 95% CI: 1.96 - 4.74), QT dispersion more than 40 (OR = 5.08; 95% CI: 3.61 - 7.15), heart rate (more than 100 versus less than 60 OR = 2.86; 95% CI: 1.03 - 7.9), ST segment elevation myocardial infarction (OR = 3.93; 95% CI: 2.63 - 5.86), poor progression (OR = 2.33; 95% CI: 1.56 - 3.49), hypertrophy (OR = 1.97; 95% CI: 1.02 - 3.81), and Sokolow-Lyon (OR = 2.91; 95% CI: 1.64 - 5.16). Conclusions: Electrocardiographic examination of COVID-19 patients is important during admission and after discharge. Sokolow-Lyon voltage less than 10 can be regarded as an independent predictor of mortality in COVID-19 patients discharged from hospital.

show abstract